Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Estrogens and selective e… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Estrogens and selective estrogen receptor modulators differentially antagonize Runx2 in ST2 mesenchymal progenitor cells

Artikel i vetenskaplig tidskrift
Författare Y. Amzaleg
J. Ji
D. Kittivanichkul
Anna E Törnqvist
Sara H Windahl
E. Sabag
A. B. Khalid
H. Sternberg
M. West
J. A. Katzenellenbogen
S. A. Krum
N. O. Chimge
D. E. Schones
Y. Gabet
Claes Ohlsson
B. Frenkel
Publicerad i Journal of Steroid Biochemistry and Molecular Biology
Volym 183
Sidor 10-17
ISSN 0960-0760
Publiceringsår 2018
Publicerad vid Centre for Bone and Arthritis Research
Institutionen för medicin, avdelningen för invärtesmedicin och klinisk nutrition
Sidor 10-17
Språk en
Länkar dx.doi.org/10.1016/j.jsbmb.2018.05....
Ämnesord Osteoblast, Osteoclast, Alkaline phosphatase, Raloxifene, Lasofoxifene, Puerarin, osteoblast differentiation, androgen receptor, breast-cancer, bone-marrow, postmenopausal women, alpha, osteoporosis, deficiency, cbfa1, gene, Biochemistry & Molecular Biology, Endocrinology & Metabolism
Ämneskategorier Biokemi och molekylärbiologi

Sammanfattning

Estrogens attenuate bone turnover by inhibiting both osteoclasts and osteoblasts, in part through antagonizing Runx2. Apparently conflicting, stimulatory effects in osteoblast lineage cells, however, sway the balance between bone resorption and bone formation in favor of the latter. Consistent with this dualism, 17 beta-estradiol (E2) both stimulates and inhibits Runx2 in a locus-specific manner, and here we provide evidence for such locus specific regulation of Runx2 by E2 in vivo. We also demonstrate dual, negative and positive, regulation of Runx2-driven alkaline phosphatase (ALP) activity by increasing E2 concentrations in ST2 osteoblast progenitor cells. We further compared the effects of E2 to those of the Selective Estrogen Receptor Modulators (SERMs) raloxifene (ral) and lasofoxifene (las) and the phytoestrogen puerarin. We found that E2 at the physiological concentrations of 0.1-1 nM, as well as ral and las, but not puerarin, antagonize Runx2-driven ALP activity. At >= 10 nM, E2 and puerarin, but not ral or las, stimulate ALP relative to the activity measured at 0.1-1 nM. Contrasting the difference between E2 and SERMs in ST2 cells, they all shared a similar dose-response profile when inhibiting preosteoclast proliferation. That ral and las poorly mimic the locus-and concentration-dependent effects of E2 in mesenchymal progenitor cells may help explain their limited clinical efficacy.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?